Long-term Retinoblastoma Survivors at Greater Risk of Dying from Subsequent Cancers (05/11/2009) Long-term retinoblastoma survivors are at a greater risk of dying from subsequent cancers and this elevated risk extends beyond 40 years, according to the results of a study published in the Journal of the National Cancer Institute.
Retinoblastoma Survivors Face Risk of Second Cancers (02/05/2009) A study that followed retinoblastoma survivors for up to 61 years reported a high risk of second cancers among survivors of hereditary retinoblastoma. These results were published in the Journal of the National Cancer Institute.
Chemotherapy for Retinoblastoma Delivered Directly into Eye May Save Eye (03/27/2008) Chemotherapy delivered directly into the artery of the eye may save the eyeball in children with retinoblastoma. These results were recently published in an early online publication in the journal Opthamology
Patients with Hereditary Retinoblastoma Have Increased Risk of Soft-tissue Sarcomas (01/03/2007) According to an article recently published in the Journal of the National Cancer Institute, patients diagnosed with retinoblastoma have a greater risk than the general public of developing soft-tissue sarcomas within their lifetime.
Chemotherapy May Allow Preservation of the Eye and Avoidance of Radiation Therapy for Children with Early-Stage Retinoblastoma (02/14/2002) Treatment for retinoblastoma, a cancer of the eye that occurs in children, is often successful with surgical removal of the eye and followup radiation therapy. However, this treatment involves the loss of an eye as well as the potential long-term side effects of radiation therapy, such as interference with a child’s growth and development and the occurrence of a second cancer later in life. In a recent study, researchers found that children with early-stage retinoblastoma may be able to keep the affected eye(s) and avoid radiation therapy by receiving 6 cycles of a chemotherapy combination.
▪ More...